Denali Therapeutics Inc. DNLI Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Returns | ||||||
| Return on equity | -49.6%-3.9pp | -45.7%-1.3pp | -44.4%-4.8pp | -39.7%-4.5pp | -35.2%+2.2pp | |
| Return on invested capital | -64.8%-8.0pp | -56.8%-6.0pp | -50.8%-4.2pp | -46.6%-6.3pp | -40.3%+7.0pp | |
| Liquidity | ||||||
| Current ratio | 9.3×+0.1× | 9.2×-0.6× | 9.8×-0.5× | 10.3×+0.7× | 9.6×+1.1× | |
| Leverage | ||||||
| Debt-to-equity | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Per Share | ||||||
| Book value per share | $4.96-15.5% | $5.87+9.3% | $5.37-10.3% | $5.99-8.6% | $6.56-12.3% | |
| Valuation | ||||||
| Market capitalization | $3.04B+18.1% | $2.58B+21.4% | $2.12B+1.5% | $2.09B+6.0% | $1.97B-32.7% | |
| Price / book | 3.3×+0.7× | 2.5×+0.3× | 2.3×+0.3× | 2×+0.3× | 1.8×-0.6× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Denali Therapeutics Inc.'s ratios come from?
- Every ratio is computed from Denali Therapeutics Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.